Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Epigenetics and Nuclear Signaling Chromatin Binding Proteins Methyl Lysine

IPA 3, Group I, p21-activated kinase (PAK) inhibitor (ab141014)

Price and availability

234 528 ₸

Availability

Order now and get it on Friday March 05, 2021

Key features and details

  • Group I, p21-activated kinase (PAK) inhibitor
  • CAS Number: 42521-82-4
  • Purity: > 97%
  • Soluble in DMSO to 100 mM and in ethanol to 25 mM
  • Form / State: Solid
  • Source: Synthetic

You may also be interested in

Product image
Human CBX1 (HP1 beta) knockout HEK-293T cell lysate (ab257383)
Product image
Anti-Swi6 antibody (ab188276)
Product image
Anti-GLYR1 antibody [EPR10076(B)] (ab154838)
Product image
Anti-FAM208A antibody (ab224393)

Overview

  • Product name

    IPA 3, Group I, p21-activated kinase (PAK) inhibitor
  • Description

    Group I, p21-activated kinase (PAK) inhibitor
  • Biological description

    Group I, p21-activated kinase (PAK) inhibitor (IC50 = 2.5 μM). Non-ATP competitive, allosteric inhibition in vivo. Selectivity over >200 other kinases.

  • Purity

    > 97%
  • CAS Number

    42521-82-4
  • Chemical structure

    Chemical Structure

Images

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.